Levothyroxine Amdipharm Limited

Levothyroxine Sodium, the active ingredient in Levothyroxine Amdipharm Limited, is a thyroid hormone presented as an oral tablet for oral use. It replaces deficient endogenous thyroid hormone and is used to manage hypothyroidism, goiter, and to suppress thyroid cancer recurrence.

GNH USA supplies Levothyroxine Amdipharm Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is distributed to healthcare providers globally.

Levothyroxine sodium is used to treat disorders of thyroid hormone deficiency and related conditions.

- Hypothyroidism: restores normal thyroid hormone levels, improving metabolism and symptom control. - Goiter: reduces thyroid‑stimulating hormone stimulation, helping to shrink gland size. - Thyroid cancer suppression: provides exogenous thyroxine to suppress TSH, lowering risk of tumor recurrence.

Levothyroxine may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Palpitations: sensation of rapid or irregular heartbeat. - Nervousness or anxiety: transient emotional changes. - Weight loss: unexpected decrease in body weight. - Insomnia: difficulty falling or staying asleep. - Diarrhea: loose stools without blood.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Angina pectoris: chest pain due to myocardial ischemia. - Osteoporosis: reduced bone mineral density with long‑term overtreatment. - Allergic reactions: rash, pruritus, or angioedema. - Myopathy: muscle pain or weakness, especially with excess dosing.

Levothyroxine requires careful monitoring and individualized dosing.

- Dose adjustment: titrate based on serial TSH and free T4 measurements. - Cardiovascular disease: monitor for angina, arrhythmias, or exacerbation of ischemic heart disease. - Elderly patients: initiate therapy at lower doses to avoid overtreatment. - Pregnancy: assess risk/benefit; dosage may need adjustment to maintain euthyroid state. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Levothyroxine interacts with several medicines that can alter its absorption or metabolism.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levothyroxine absorption. - Calcium supplements: impair intestinal uptake of the drug. - Iron salts: decrease bioavailability when taken concurrently. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Certain cholesterol‑lowering agents (e.g., cholestyramine): bind levothyroxine and lower its effectiveness.

Moderate Interactions (Monitor Closely): - Rifampin: induces hepatic enzymes, increasing levothyroxine clearance. - Oral contraceptives: may increase levothyroxine requirement. - Proton‑pump inhibitors: can modestly reduce absorption, necessitating TSH monitoring.